FindTrial
Sign In

3.0T Magnetic Resonance Diffusion Weighted Imaging of esophageal cancer in the assessment of response to neoadjuvant chemotherapy

3.0T Resonance Diffusion Weighted MRI for esophageal cancer neoadjuvant chemotherapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DOD-14005322
Enrollment
Unknown
Registered
2014-10-13
Start date
2014-10-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer

Interventions

Gold Standard:
Index test:

Sponsors

Henan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients have biopsy proved esophageal cancer and can underwent MRI before surgery; 2. Underwent neoadjuvant chemotherapy preoperation; 3. pathological confirmation after radical resection of oesophageal cancer.

Exclusion criteria

Exclusion criteria: Cases which not be satisfied with any item in inclusion criteria.

Design outcomes

Primary

MeasureTime frame
ACC;sensitivity;specificity;—

Countries

China

Contacts

Public ContactJianjun Qin
qinjianjun73@aliyun.com+86 13838008630

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026